Immune cell generation

"Immune cell generation" refers to the process by which hematopoietic stem cells in the bone marrow differentiate into various types of immune cells, notably T cells, B cells, NK cells, dendritic cells, macrophages, and granulocytes[1][6]. This process requires regulatory signals from soluble mediators (cytokines), cell-cell interactions, and specific gene expression events (such as somatic recombination for T and B cell receptor diversity)[1][2]. T cells undergo further maturation in the thymus, while B cells mature in the bone marrow. The process is essential for both innate and adaptive immunity, enabling the body to recognize and respond to pathogens, maintain tolerance to self-antigens, and support immune memory[1][3][5][6]. Aberrations in immune cell generation may lead to immunodeficiency, autoimmunity, inflammatory disorders, or hematological malignancies. While drugs such as colony-stimulating factors (G-CSF, GM-CSF), erythropoietin, or interleukins can modulate specific aspects of immune cell development, "immune cell generation" itself is not a single molecular target for therapy; instead, its regulation encompasses numerous signaling pathways and cellular checkpoints[1][6].

Other names

Immune cell developmentHematopoiesisLymphopoiesisMyelopoiesisImmune cell differentiation